Switch to: Citations

Add references

You must login to add references.
  1. Corporate Disguises in Medical Science: Dodging the Interest Repertoire.Sergio Sismondo - 2011 - Bulletin of Science, Technology and Society 31 (6):482-492.
    Roughly 40% of the sizeable medical research and literature on recently approved drugs is “ghost managed” by the pharmaceutical industry and its agents. Research is performed and articles are written by companies and their agents, though apparently independent academics serve as authors on the publications. Similarly, the industry hires academic scientists, termed key opinion leaders, to serve as its speakers and to deliver its continuing medical education courses. In the ghost management of knowledge, and its dissemination through key opinion leaders, (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • Beyond Speaking Truth? Institutional Responses to Uncertainty in Scientific Governance.Cordula Kropp & Kathrin Braun - 2010 - Science, Technology, and Human Values 35 (6):771-782.
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • At Home in the Seamless Web: Agency, Obduracy, and the Ethics of Metropolitan Growth.Robert Kirkman - 2009 - Science, Technology, and Human Values 34 (2):234-258.
    Political responses to metropolitan growth in the United States and elsewhere should include careful ethical deliberation, but ethical judgment and action are limited by the involvement of individual moral agents in the complex processes that give shape to the built environment. I propose that casting the built environment as a heterogeneous sociotechnical ensemble can provide useful insight into the limits of ethics, particularly through the concept of obduracy. To the extent components of an ensemble are obdurate, they can stop or (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? [REVIEW]Josephine Johnston, Marcia Angell & Sheldon Krimsky - 2004 - Hastings Center Report 34 (5):44.
    Download  
     
    Export citation  
     
    Bookmark   68 citations  
  • Doubt is Their Product.David Michaels - 2008 - Oxford University Press.
    "Doubt is our product," a cigarette executive once observed, "since it is the best means of competing with the 'body of fact' that exists in the minds of the general public. It is also the means of establishing a controversy." In this eye-opening expose, David Michaels reveals how the tobacco industry's duplicitous tactics spawned a multimillion dollar industry that is dismantling public health safeguards. Product defense consultants, he argues, have increasingly skewed the scientific literature, manufactured and magnified scientific uncertainty, and (...)
    Download  
     
    Export citation  
     
    Bookmark   89 citations  
  • The Price of Truth: How Money Affects the Norms of Science.David B. Resnik - 2007 - New York, US: Oup Usa.
    Modern science is big business. Governments, universities, and corporations have invested billions of dollars in scientific and technological research in the hope of obtaining power and profit. For the most part, this investment has benefited science and society, leading to new discoveries, inventions, disciplines, specialties, jobs, and career opportunities. However, there is a dark side to the influx of money into science. Unbridled pursuit of financial gain in science can undermine scientific norms, such as objectivity, honesty, openness, respect for research (...)
    Download  
     
    Export citation  
     
    Bookmark   44 citations  
  • Do artifacts have politics?Langdon Winner - 1980 - Daedalus 109 (1):121--136.
    In controversies about technology and society, there is no idea more pro vocative than the notion that technical things have political qualities. At issue is the claim that the machines, structures, and systems of modern material culture can be accurately judged not only for their contributions of efficiency and pro-ductivity, not merely for their positive and negative environmental side effects, but also for the ways in which they can embody specific forms of power and authority. Since ideas of this kind (...)
    Download  
     
    Export citation  
     
    Bookmark   327 citations  
  • Deadly Dust: Silicosis and the Politics of Occupational Disease in Twentieth-Century America.David Rosner & Gerald Markowitz - 1993 - Science and Society 57 (1):111-114.
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles.Lenard Lesser, Cara Ebbeling, Merrill Goozner, David Wypij & David Ludwig - 2007 - Plos Medicine 4 (1):e5.
    Download  
     
    Export citation  
     
    Bookmark   15 citations  
  • Pharmaceutical company funding and its consequences: A qualitative systematic review.Sergio Sismondo - manuscript
    This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.
    Download  
     
    Export citation  
     
    Bookmark   18 citations